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ABSTRACT 
Culture media play a very important role in bacteriology as they are used in the isolation, identification and antimicrobial 
susceptibility testing. It is essential that the quality of media be safeguarded to have a successful microbiology laboratory. 
Microorganisms usually show typical morphological appearance and properties on solid media. Variations in the composition 
of the medium may alter this appearance and properties. There is therefore a need to ensure good quality media, which is 
capable of giving satisfactory results by ensuring a proper quality management system. Often times, majority of laboratories 
prepare their media for routine diagnostics and research purposes. Therefore, it is essential that certain parameters of media are 
checked thoroughly before they are considered suitable for laboratory use. Control methods are discussed in details in this 
report. 
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ABSTRAIT 
Les milieux de culture jouent un rôle très important en bactériologie, car ils sont utilisés dans les tests d'isolement, 
d'identification et de sensibilité aux antimicrobiens. Il est essentiel que la qualité des médias soit garantie pour avoir un 
laboratoire de microbiologie performant. Les micro-organismes présentent généralement une apparence morphologique et des 
propriétés typiques sur des milieux solides. Des variations dans la composition du support peuvent altérer cet aspect et ces 
propriétés. Il est donc nécessaire de garantir des supports de qualité, capables de donner des résultats satisfaisants en assurant 
un système de gestion de la qualité approprié. Souvent, la majorité des laboratoires préparent leurs médias à des fins de 
diagnostic et de recherche de routine. Par conséquent, il est essentiel que certains paramètres des supports soient soigneusement 
vérifiés avant de pouvoir être considérés comme pouvant être utilisés en laboratoire. Les méthodes de contrôle sont discutées en 
détail dans ce rapport. 
 
BACTERIOLOGY LABORATORY 
Source of Media  
In the past, bacteriologic media were prepared from 
the basic chemical ingredients but this is no longer a 
common practice as many laboratories no longer do 
this. Rather, commercially-prepared dehydrated 
media which requires only the addition of water in 
for its reconstitution and use are now routinely used 
by most laboratories. Hence, the responsibility of 
quality control is that of the manufacturer however 
the quality of the media must be tested after its 
preparation due to changes which can occur 
following reconstitution and sterilization(1). For these 
dehydrated media, quantities ordered should be used 
up within 6 months or at most one year. It should be 
stored in a cool, dark, well ventilated place with the 
caps of all containers sealed tightly as dehydrated 
media are hygroscopic. Date of receipt and opening of 
media should be recorded. Darkened or caked 
dehydrated media must be discarded (2).    
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Often times, certain additives such as blood, serum, 
growth factors, specific vitamins, antibiotics are used 
in the preparation of media especially for fastidious 
organisms. The quality of blood used in the 
preparation of blood-containing media is essential to 
the performance of the media. The sterility, viscosity, 
homogeneity and colour of the blood should be 
carefully checked prior to its use for media 
preparation (3).  In the case of other additives, the 
certificate of analysis and sterility conditions should 
be considered prior to usage while heat labile 
additives whose sterility is uncertain can be sterilized 
by membrane filtration (4).  Commercially-prepared, 
ready to use media are also available and utilized by 
some laboratories. The quality control maintenance of 
such media is the responsibility of the manufacturer. 
A written assurance must be supplied by the 
manufacturer stating that Clinical and Laboratory 
Standards Institute (CLSI) standards were followed 
and this verification must be maintained along with 
the QC protocol of the laboratory for as long as the 
laboratory uses the specified media.4  In addition, a 
certificate of analysis stating the expiration date, 
storage conditions  should accompany all 
commercially-prepared, ready to use media along 
with quality control organisms used in growth 
supporting ability and selectivity testing (5).  
However, the laboratories also need to inspect each 
shipment of media for its properties (1,4).   
Quality and Quantity of Water   
The quality of any media depends directly on the 
quality of raw materials used in its preparation with 
water being the most important raw material (6). Tap 
water should not be used in media preparation due to 
the presence of impurities rather distilled and/or 
deionized water should be used.1 The copper content, 
pH and conductivity of the water should be checked 
prior to its use in the preparation of culture media. 
Ideally, water used should have no copper in it 
because of its inhibitory effect on microorganisms. 
The pH of the water should be slightly acidic but not 
less than 5.5 while the conductivity should not be less 
than 15 µS (microsiemens) (3).  The amount of water 
added while reconstituting media should be carefully 
measured in order to have adequate gel strength (1,3).   
Weighing 
Weighing balances used in the measurement of dry 
materials must be accurate as weighing errors 
significantly alter the composition of the final product 
(1).   
Quality of Glassware 
Glassware used in media preparation should be made 
of borosilicate glassware, as glassware made of soda 
can leach alkali into the media resulting in an 
alteration of the pH of the media.3 Glassware used 
should be carefully cleaned as residues on glass may 
be inhibitory in some fastidious organisms (1).   
Quality of Sterilization 
The process of sterilization also plays an important 
role in the quality of culture media. Generally, culture 
media is sterilized by autoclaving. But, certain 
parameters must be met in order to achieve adequate 
sterilization. These include the autoclaving time, 
temperature and pressure as well as close regulation 
of the quantity of media sterilized. Heat treatment of 
complex culture media may result in destruction of 
nutrients present in the media either by direct thermal 
destruction or reaction between its components. 
Sterilization of media at too high a temperature or for 
too long or both may result in the deterioration of 
some constituents of the media thereby rendering it 
unsuitable for use (1).  Hence, it is necessary to 
minimize the heating damages by optimizing the 
heating process. The autoclave time to achieve 
sterility at a temperature of 121℃ (250℉) is 15 
minutes while the autoclave pressure is 15 psi 
(100KPa).4 The volume of media in a sterilization 
batch should be small, ideally 2 Litres (3).   
Regular checking of the sterilization process by the 
use of indicators is essential; the temperature and 
pressure should also be monitored constantly. 
Sterilization indicators are used to check the efficacy 
of the sterilization process. Biological sterilization 
indicators such as the spores of Bacillus 
stearothermophilus can be used to check the spore 
killing efficacy while the chemical indicator such as 
Bowie Dick test can be used to check the efficiency of 
the sterilization process (3).   
The physical appearance of the media should be 
inspected after sterilization as there might be 
alteration in its appearance. The following may be 
observed: turbidity or a precipitate indicating that 
some constituent has come out of the solution; darker 
than normal colour indicating overcooking of sugar 
containing media, incorrect mixture of constituents or 
wrong pH; lighter than normal colour indicating 
incorrect mixture of constituents or wrong pH (1).   
Dispensing 
The quality of the Petri dish used in the preparation 
of the media is also important. Petri dishes are 
normally sterilized with ethylene oxide (Eto) or 
gamma irradiation. Eto sterilized Petri dishes should 
be checked for residual Eto toxicity which may inhibit 
the growth of microorganisms. The maximum 
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permissible limit for residual Eto is 1 µg/g. Residual 
Eto can be measured by standard gas 
chromatographic method (3).  Aseptic technique is 
essential while dispensing media and accurate 
volume should be dispensed. About 25-30 ml of 
media should be dispensed into a 100 mm Petri dish. 
Inaccurate measurement of the amount of media may 
result in too shallow or too deep media rendering it 
unsuitable for use(1).   Media should be dispensed 
into Petri dishes on a flat, level surface in order to 
have equal filling.  
Physical Parameters of the Media 
The gross physical appearance of media is an 
indicator of its quality. All media, either user-
prepared or commercially-prepared should be 
screened for physical parameters such as colour, 
consistency, depth, smoothness, excessive bubbles or 
pits, unequal filling of Petri dishes, cracked medium 
in plate, clarity, freezing( seen as a crystalline pattern 
on the surface of the medium), presence of leakage 
and visible contamination. All these are checked 
visually by the naked eye. However, depth of the 
medium and unequal filling of Petri dishes can be 
checked at four points. The four points are the two 
ends of the two diameters of the plate which are at 
right angles to each other. The depths at the four 
points are noted, the mean thickness is calculated and 
reported as the mean thickness of the medium in the 
plate which must be 4.0±0.2 mm.3 Blood based media 
should be checked for signs of haemolysis. There 
should be no deviation from the normal colour of the 
media. It should be free of moisture but should have 
no signs of drying at the edges, Petri dishes should 
have not be broken or cracked.7 The pH of the 
medium must be checked while preparing the 
medium before and after autoclaving using a 
standard pH meter after calibration with standard 
buffers (3).    
The gel strength which is an indication of the level of 
solidification of the agar within the medium is also 
measured. This is done with the aid of a tripod stand 
with a central rod that is used to impart pressure on 
the agar. The lower end of the rod has a spherical 
portion which rests on the surface of the medium 
while the upper end of the rod has a platform on 
which standard weights are placed. The spherical part 
of the central rod is placed on the medium and then 
weights are placed on the upper platform one after 
another and observed for a while. This process is 
continued until the agar breaks under the weight of 
the central rod. The gel strength can then calculated 
by deducting the weight of the central rod from the 
total weight. The force imparted by the rod on the 
agar surface is calculated by the formula: Wpr2 where 
W is the weight of on the platform, r is the radius of 
the spherical part of the lower end of the central rod 
and p is 3.14 (a constant). The acceptable gel strength 
is about 300-500 dynes/cm (2). 
Contamination 
This is a very important indicator of the media 
quality, it is also known as sterility testing.  Each 
batch of media must be checked for contamination 
before it is declared fit for laboratory use. The 
common technique in sterility testing is randomly 
picking a small number of media (usually between 1-
5% of the batch) at random and placing in an 
incubator at a selected temperature and time 
depending on the type of media though for general 
purpose 30-37℃ for 48-72 hours is typical. After 
which the plates are checked for microbial growth. If 
there is no growth the batch is declared fit for use, the 
samples used in the sterility testing should be 
discarded as they are unsuitable for inoculation due 
to the dehydration that occurs after up to 48 hours 
incubation. If there is growth, the process is repeated. 
If there is growth again, the batch is inferred to have 
been contaminated. It is recommended that a batch be 
discarded when there is more than 10% 
contamination (8).  Alternatively, it has been 
suggested that contamination can be checked by 
leaving the whole batch of prepared media at room 
temperature for at least three days after which it is 
examined for visible growth (3).   
Growth Supporting Ability 
Growth supporting ability is the most important 
parameter when conducting quality control of a 
media. In order to demonstrate the growth promoting 
ability of media, a panel of microorganisms is 
required. Preferably, the recommended 
microorganisms should be traceable to a reputable 
culture collection such as the American Type Culture 
Collection. The media should be inoculated with 
overnight cultures of pure, well defined and 
appropriate test strains of the organism (9).   When 
testing new lots of media, the results should be 
examined both qualitatively and quantitatively while 
using standard inoculating procedures. The previous 
batch and a new batch should be simultaneously 
inoculated. Results of previous batches of the same 
media should be compared with that of a new batch. 
During testing, some priorities must be established 
such as beginning the testing with media that are 
most likely to demonstrate deficiencies. Top priority 
should be accorded to blood, chocolate and Thayer 
Martin agars and secondary priority should be given 
to selective enteric media such as MacConkey, EMB, 
XLD and bile salt containing agars (1).   Testing of 
selective media should include inoculation of 
organisms supported by the media and organisms 
inhibited by the media in order to demonstrate its 
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selective nature. To demonstrate the inhibitory effect, 
the medium can be challenged with a heavy inoculum 
of the organism, since if the medium can inhibit the 
growth of a large inoculums it will also prevent the 
growth of the small number of organisms present in 
specimens.1  When testing media used to identify a 
biochemical response such as hydrogen sulphide 
production or fermentation, species or strains of 
organisms which will produce the desired reaction 
should be used  (1).  All laboratory prepared media 
must be tested before use, using organisms expected 
to grow or not to grow or organisms expected to give 
a positive reaction or negative reaction. The 
microorganism selected should be the most fastidious 
for which the medium was designed.  For primary 
plating media, testing should be done with dilute 
suspensions of the test organism while undiluted 
organisms should be used for biochemical media (7).  
CLSI has certain guidelines for the control organisms 
used for every medium, the inoculum concentration 
desired and the growth results expected. Table 1 
shows some suggested control organisms, incubation 
conditions for some bacteriological media with their 
expected results. 
For agar-based media, the qualitative, semi-
quantitative or quantitative method can be used in 
testing for growth supporting9. Examples of the 
qualitative method is the spread plate, for the 
semiquantitative method econometric and spiral plate 
while that of the quantitative are pour plate, spread 
plate and the modified Miles-Misra also known as the 
drop count technique (1,10).  Quantitative assessment 
is more useful in testing the performance of selective 
or inhibitory media such as Thayer Martin agar (1).   
Quantitative assessment is more difficult to apply in 
liquid media, hence it is done using endpoint 
determinations and kinetic parameters. The end point 
determination focuses on the final result of growth 
which is seen as an increase in biomass. This can be 
indirectly determined by measuring the turbidity, 
changes in electrical properties such as the 
conductance of the broth, estimating the viable 
numbers within the broth, production of visible 
metabolic products such as gas, or reactive 
compounds such as indole.9,10   Examples of 
methods which utilize endpoint determinations 
include copious growth method, end point method 
and most probable number. Kinetic parameters 
involves comparison of the growth supporting ability 
of two batches of broth can be done by measuring the 
growth curves of identical inocula grown side-by-
side. The growth rate of the challenge organism is 
then determined either by viable count or 
spectrophotometrically as a means of comparing the 
nutritive properties of the media. Alternatively, 
comparison can be made using the length of lag 
phases of the same inoculums on the test and control 
broths. This method is extremely labour intensive, 
subject to variability and difficult to implement (10).  
Media Storage and Expiry 
Media that are yet to be declared fit for use should be 
quarantined, tagged unqualified and ideally placed in 
a storage room separate from that where qualified 
media is stored. An alternative is tagging and placing 
them in a clearly identified area within the same 
room. All QC checks on the quarantined media must 
be completed before its release for use. Storage 
conditions of quarantined media should be similar to 
that of qualified media (10).   
Prepared media should be stored away from sunlight 
and heat. Media containing blood, antibiotics and 
other organic additives should be stored in the 
refrigerator. When stored in a cool dry place, the shelf 
life of prepared media depends on the type of 
container used. The shelf lives typically are: 2 weeks 
for media in tubes with loose caps, 3 weeks for media 
in tubes with cotton wool plugs, 4 weeks for media in 
Petri dishes (if sealed in plastic bags) and 3 months 
for media in containers with screw-caps (2). 
TABLE 1: PERFORMANCE TESTS ON COMMONLY USED MEDIA 
Medium Control 
Organism 
Incubation condition and 
duration 
Expected Result 
Chocolate agar H. influenza CO2, 24  hours Growth 
Blood agar S. pyogenes CO2, 24  hours Growth and β-
haemolysis 
 S. pneumonia CO2, 24  hours Growth and α-
haemolysis 
Salmonella-Shigella agar or Deoxycholate 
citrate agar 
E. coli 24 hours No growth 
 S. Typhimurium 24 hours Colourless colonies 
Selenite broth S. Typhimurium 24 hours Growth after subculture 
 E. coli 24 hours No growth after 
subculture 
Bile-aesculin agar E. faecalis 24 hours Growth and blackening 
 S. pyogenes 24 hours No growth 




Documentation of the performance and sterility of all 
prepared media must be done and records must be 
maintained for 2 years (2).  For user prepared media, 
QC forms should contain the quantity prepared, 
source of the ingredient, lot number, sterilization 
date, preparation date, expiration date and the name 
of the person who prepared the media (4).    
For commercially prepared, ready-to-use media, 
sample of the lot should be tested for sterility, usually 
5% of any lot is tested in a batch of 100 units or less 
while a maximum of 10 units are tested in larger 
batches. Any one shipment of a product with the 
same lot number is considered a batch, it is 
considered a different batch if a separate shipment 
with the same lot number of a product is received and 
should be tested separately  (4).   Following the 
collection of data over several years by the CLSI 
Subcommittee on media quality control regarding the 
incidence of QC failures of commonly used 
microbiology media, a list of media which did not 
require retesting if purchased from a manufacturer 
who follows the CLSI guidelines. However, a written 
assurance stating that CLSI standards were followed 
must be supplied by the manufacturer and this 
verification must be maintained in the laboratory 
along with its QC protocol. This written assurance 
must be retained for as long as the laboratory uses the 
specified media. Some media however need to be 
retested by the laboratory due to the complexity or 
failure rate history of the media. Examples include 
chocolate agar and selective media for pathogenic 
Neisseria and Campylobacter. Each shipment must also 
be inspected for cracked media, unequal filling, 
excessive bubbles, clarity, freezing( seen as a 
crystalline pattern on the surface of the medium), 
presence of leakage and visible contamination.4 Blood 
based media should be checked for signs of 
haemolysis. There should be no deviation from the 
normal colour of the media. It should be free of 
moisture but should have no signs of drying at the 
edges, Petri dishes should have not be broken or 
cracked (7).      The results of media observations 
should be recorded along with their lot numbers. 
When a medium does not meet the standards, 
corrective action must be taken and this should be 
documented on a separate record called media 
failures log.  
In antimicrobial susceptibility testing, variability in 
the content of the media can affect the accuracy of the 
results obtained. Mueller-Hinton agar will be used in 
this article as it is best media for routine antimicrobial 
susceptibility testing of non-fastidious bacteria. 
Fastidious bacteria such as Haemphilus influenza, 
Neisseria gonorrhoeae, Neisseria meningitides and 
Stroptococcus pneumoniae do not grow well on un-
supplemented  Mueller-Hinton agar hence they 
require supplements or different media for their 
growth.  Quality control of a batch or lot of Mueller 
Hinton is done by testing each batch or lot of agar 
plates or disks with the appropriate quality control 
strains to determine if the sizes of the zones of 
inhibition obtained within the batch fall within the 
expected range. The acceptable zone diameter quality 
control limits for a single quality control test (single 
test/single-organism combination) are listed in CLSI 
M100-S22, Tables 3A and 3B.  For non-fastidious 
bacteria, significant variations might exist in the 
results obtained with some batches of Mueller-Hinton 
agar due to its inability to support adequate growth 
of the test organism. Factors which can result in such 
variations include: 
1) Cation content: increase in Ca2+ and Mg2+ 
contents cause a false resistance of P. 
aeruginosa to the aminoglycosides and a false 
resistance of microorganisms to tetracyclines 
and vice versa. Ca2+ and/ or Mg2+ content 
can be verified by performing antimicrobial 
susceptibility test on Pseudomonas aeruginosa 
ATCC 27853 and obtaining correct zone 
diameters with the aminoglycosides. 
Variation in the Ca2+  also affects the results 
of daptomycin as low calcium content causes 
a false resistance to daptomycin and vice 
versa. The recommended Ca2+ content in 
Mueller-Hinton agar for optimal daptomycin 
activity is 50 mg/L which is similar to the 
physiological levels. Excess zinc ions in the 
medium may reduce the sizes of the zones of 
inhibition of carbapenems (11).      
2) pH: The acceptable pH range of Mueller-
Hinton agar is 7.2-7.4 at room temperature. 
The pH of each batch of the medium should 
be checked before and after gelling. A 
reduction in the pH of the media gives a 
false resistance of microorganisms to 
aminoglycosides, clindamycin, macrolides, 
quinolones and a false susceptibility of 
microorganisms to the penicillins and 
tetracyclines and vice versa. The pH of the 
media can be checked by macerating enough 
agar to submerge the tip of a pH electrode, 
by allowing a small amount of agar to 
solidify around the tip of a pH electrode in a 
beaker or by the use of a surface electrode.  
Incubation of the medium in CO2 should be 
avoided as it can result in a decrease in the 
pH (11).         
3) Thymidine and thymine content: The 
thymidine content in Mueller-Hinton agar 
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should be as low as possible. Mueller-Hinton 
agar with excessive thymidine or thymine 
content can reverse the inhibitory effect of 
sulfonamides and trimethoprim thereby 
causing a false resistance to sulfonamides, 
trimethoprim, and trimethoprim-
sulfamethoxazole. Evaluation of the 
thymidine or thymine content in Mueller-
Hinton agar can be done by testing 
trimethoprim-sulfamethoxazole disks 
against Enterococcus faecalis ATCC 29212 or 
E. faecalis ATCC 33186. Clear, distinct zones 
of inhibition  ≥ 20 mm is  seen in a 
satisfactory medium while unsatisfactory 
medium will have no zone of inhibition, 
growth within the zone of inhibition or a 
zone of inhibition< 20 mm (11).      
4) Moisture (when using Bauer-Kirby test): 
The surface of the medium should be moist 
but droplets of moisture should not be 
apparent on the surface of the medium or on 
the Petri dish covers during inoculation of 
the plates. Plates with excess moisture 
should be placed in an incubator at 35℃ or 
in a laminar flow hood at room temperature 
with lids ajar until excess moisture is 
removed by evaporation. This usually takes 
about 10 to 30 minutes (11,12).       
5) Agar depth (when using Bauer-Kirby test): 
the media should have a uniform depth of 
about 4 mm. This corresponds to 60-70ml of 
medium for 150 mm diameter plates and 25 
to 30 ml for 100 mm diameter plates (11,12).        
 
QUALITY CONTROL OF VIROLOGICAL MEDIA 
Isolation of viruses is still the gold standard in the 
diagnosis of infections due to viruses however, not all 
viruses are culturable. Viral cultures are expensive 
not only in terms of media, reagents and disposables 
but also in the time taken to propagate and prepare 
cell lines, extract the virus from the sample, apply the 
viral extract to the cell line and diagnose the outcome 
of the assay. Hence, it is essential to maintain strict 
quality control in order to maximize the performance 
of the cell line and limit negative effects of variables 
which can directly or indirectly affect the assay 
outcome. There are three methods used in the 
isolation of viruses in diagnostic virology namely: cell 
culture, animal inoculation and embryonated eggs. 
The most commonly used method in clinical virology 
is cell culture as animal inoculation is extremely 
costly and cumbersome while embryonated eggs are 
too expensive and inconvenient for use in the routine 
diagnostic laboratory though they are used for 
vaccine production (13).       Cell culture is technically 
the culture of cells in vitro. Tissue or organ culture 
denotes the growth of tissues or organ is preserved. 
Clinical virologists usually use these terms 
interchangeably but cell culture is technically more 
correct. Previously, a lot of diagnostic virology 
laboratories initiated and propagated their own cell 
lines but now there are several commercially 
prepared cell lines which are more convenient and are 
commonly purchased. Quality is important in all 
aspects of cell culture as the quality of materials i.e. 
cell lines, media and other reagents affects the quality 
of the cultures and products derived from them. 
Hence, the main areas of concern in quality control of 
cell culture are: quality of reagents and material; 
provenance and integrity of the cell lines and 
avoidance of microbial contamination. The 
work/laboratory environment, equipment and 
personnel also affects the quality of virological media 
produced hence a brief mention on factors peculiar to 
the virology laboratory will be mentioned.  
Facility Design 
The virology laboratory space must be physically 
separate from the microbiology laboratory space with 
dedicated equipments and biosafety cabinets 
(minimum of level 2).  Temperature must be 
maintained at 22-26℃ and relative humidity of 30-
50%. There should be dedicated areas for reagent 
preparation, sample preparation and analysis. There 
should be dedicated hoods/biosafety cabinets for the 
preparation of cell lines, sample processing during 
viral analysis by tissue culture (14).       Work surface 
areas must be made of material allowing regular 
decontamination. Waste should be segregated 
properly and disposed by following standard hospital 
infection control policies (15).        
Reagents, Supplies and Equipment 
Supplies of items such as glassware, plastic ware, 
reagents, commercially prepared culture media and 
laboratory equipment should be of high quality 
because they are crucial to the quality of results 
obtained. There should be consistent supply of all 
items and technological support of equipment. 
Quantity, lot number, source and date of receipt 
should be entered into a log book upon receipt. All 
supplies and consumables should be stored in 
appropriate conditions specified by the 
manufacturer.14 The reagents and materials are 
potential sources of contamination hence materials of 
good quality free from microbial contamination and 
breakage should be used. Materials and reagents for 
cell culture can be obtained from manufacturers who 
carry out a range of quality control tests screening for 
microbial contamination such as Mycoplasma and 
bovine viral diarrhoea virus (BVDV) (16).        
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Sterility testing should be carried out on cell culture 
flasks prior to their use by using a nonselective, 
antimicrobial free cell culture media. For prepared 
media, pyrogen-free water should be used, preferably 
Type 1 reagent grade water and this must be used as 
soon as it is produced because of leaching of metals or 
organic contaminants from the storage container into 
the water, bacterial contamination as well as a 
decrease in the resistivity which will occur (16).         
Sanitization of pH probes, hoses, pumps and filter 
housings should be done using 0.525% solution of 
sodium hypochlorite which must be followed by 
neutralization using 1M solution of sodium 
thiosulfate. Fine instruments should be frequently 
serviced and calibrated by accredited service agencies  
(16).        
Media: Every lot of culture media and supplements 
must be tested to confirm the support of the growth 
of the cell line and propagation of viruses are not 
affected negatively in the various assay formats. 
Media supplements such as serum or semi-synthethic 
serum surrogates which can affect the impact of cell 
growth and virus propagation must be evaluated 
prior to usage. A new lot of serum should be tested 
with all cell lines to evaluate the overall growth 
characteristics. Each lot of serum can be spiked with 
the various virus stock cultures in order to ensure it is 
not inhibitory to the virus infection, multiplication 
and it allows for production of sufficient virus titer. 
This evaluation should be done well in advance of 
exhaustion of the current lot of supplements and 
media. The entire process might take 4-6 weeks and 
consume laboratory resources hence sufficient time 
and careful planning is needed (14).         
There may be significant variations in the sensitivity 
to virus isolation and this may depend on the cell sub-
line or clone and the number of times passaged. 
Hence, information on a particular cell line including 
the source, type, number of times passaged, 
confluency and cell condition should be recorded. 
There should be provisions for back-up of routinely 
passaged cells in case of contamination or laboratory 
accident in order to avoid severe disruption of 
workflow. This back up can be done by freezing and 
storage of low passage cells at -70℃, use of aired stock 
flasks or carrying of a parallel set of stock flasks using 
a separate set of tissue culture reagents and 
glassware.  
Most reagents and media used in cell culture can be 
sterilized either by autoclaving (for heat stable 
components e.g. water, salt solutions, amino acid 
hydrolysates) or membrane filtration (for heat labile 
components). The appropriate type of filter 
membrane should be selected for use. Cellulose 
acetate membranes are used for applications 
involving low protein binding while cellulose nitrate 
membranes are used for general purpose filtration. 
The pore size of the membrane should be 0.22µM in 
order to achieve sterilization. Thick cotton 
membranes or pads which have larger pore sizes can 
be used for pre-filtering.16 Sterility testing of the 
media should be done after filter sterilization. 
Aliquots of the media are obtained and examined for 
bacterial and fungal contamination. This should be 
done daily for 5 days and free from contamination 
before the lot is declared fit for use. Aliquots of all 
media components and supplements such as foetal 
calf serum and L-glutamine should also be checked 
for sterility (11).        
Several organisms such as bacteria, yeasts and fungi 
may contaminate cell cultures. They are detected as 
turbidity or a change in the pH of the culture 
medium. However, organisms such as Mycoplasma 
and viruses do not cause turbidity or change in pH. 
They may or may not cause cytopathological effects 
(CPE) in the cell line. Thus, they are difficult to detect 
and may be passaged indefinitely without being 
detected. Cell lines which are notorious for 
adventitious virus contamination include primary 
rhesus monkey kidney cells, primary bovine kidney 
cells and primary African green monkey kidney cells. 
Hence cell lines must be tested for microbial 
contamination prior to use. This can be done by 
screening the cell lines can be screened for 
Mycoplasma contamination using DNA specific 
fluorescent staining and further confirmed by culture. 
Also available are commercial testing services for 
Mycoplasma and viruses such as MycoTect test  (14).        
Cell lines prepared by the laboratory should be 
subjected to daily growth rate and contamination 
checks, every month, Hoechst stain should be used to 
detect Mycoplasma contamination and the sensitivity 
of the cell line to viral isolation should be monitored 
by periodic TCID50 experiments with stocks of 
reference virus.15 Mycoplasma contamination can also 
result in altered growth rate, morphological changes, 
chromosome aberrations or alteration in amino acid 
and nucleic acid metabolism. Daily microscopic 
examination of the cultures ensures early detection of 
contamination and initiation of appropriate action. 
Close observation of the medium for colour changes 
is important as it indicates an increase or decrease in 
pH and rate of metabolism, this is essential as it 
determine if the cells need feeding or subculturing as 
epithelial cell lines such as HeLa and Hep2 have a 
rapid metabolism. Fibroblast cells such as MRC5 and 
WI-38 have a slower metabolism and therefore need 
feeding at least once a week and subculturing only 
once a week  (16).   Commercially prepared cells 
should be certified to be free from Mycoplasma, fungal 
and bacterial contamination and examined for 
contamination upon receipt.  
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Instruction sheets should accompany cells purchased 
from cell repositories as they contain 
recommendations on the appropriate medium, 
subculture procedures, correct seeding 
concentrations, feeding schedule and safety concerns. 
There should be daily checks of cells to ascertain 
growth rate and contamination. During use, cell lines 
should be handled separately and the cabinet 
decontaminated in between. Chances of 
contamination can be further minimized by the use of 
separate apparel, reagents and glassware for cell 
culture and exclusion of laboratory with infectious 
diseases from handling cell culture (14).   
Contaminated cell culture should be discarded upon 
detection and the work continued with earlier stocks 
known to be free of contaminants or obtain fresh 
stocks from a recognized source. 
During cell culture, cells adherent to the cell culture 
flask can either be detached physically or chemically. 
In physical detachment, disposable cell scrapers 
should be used. This is done by removing the growth 
medium after which the cells are physically detached 
by scraping the cells from the surface of the flask.  
Chemical detachment involves the use of enzymes 
(such as trypsin, pronase or collagenase) and 
chelating agents (such as ethylene-diamine-tetra-
acetic acid or versene) for the detachment process. 
Care must be taken when handling cell monolayers as 
the enzymes used in the detachment may be toxic to 
some cells. Some enzymes also remove important 
receptors and cell surface molecules which are 
important hence the effects on the enzymes on the 
chosen cell line must be known prior to its use  (13).        
Personnel and Environmental Monitoring 
 Individuals working with cell culture should wash 
hands upon entry into the laboratory in order to 
remove dry skin and loosely adherent 
microorganisms which are potential sources of 
contaminants. Surgical gloves and gowns must be 
worn and gloves must be frequently swabbed with 
70% (v/v) sterile isopropanolol.  Cabinets should be 
stocked with all materials needed in a clutter-free 
manner prior to the commencement of any procedure. 
All items that enter the biosafety cabinet must be 
sprayed with 70% (v/v) sterile isopropanolol to 
prevent dust and particles from entering into the 
cabinet. Avoid creating bubbles or generating 
aerosols in the medium or pipette as they can act as 
sources of contamination. Preferably, a pipette should 
be used only once and clean spills with 70% (v/v) 
sterile isopropanolol immediately they arise. 
Personnel should be with proven expertise. They 
should have training and experience in media and 
reagents preparation, preparation of dilutions, cell 
line manipulation, handling harvesting and 
distribution of cells, maintenance of cell cultures and 
the outcome of assays. They should be accurate in 
documentation. Poorly trained staff can also in core 
areas such as good laboratory practice and aseptic 
techniques are potential sources of contamination of 
the media especially during manipulation. They 
should undergo re-training. The training and 
experience of staff and laboratory activities 
documentation enhance quality of results obtained in 
the virology laboratory (14).        
The importance of ensuring the quality of media 
medical microbiology and virology laboratory cannot 
be overemphasized as media of low quality will lead 
to problems with every aspect of the laboratory 
operation. For accurate and acceptable isolation of 
pathogens, QC testing of media using a standard 
protocol helps save time and resources. As the time 
and resources spent on ensuring production of 
quality media will be amply repaid in terms of 
reproducibility of data and reduction on the time 
spent on investigations of non-conforming results.  
INTERNAL QUALITY CONTROL 
The issue of quality control (QC) in the medical 
microbiology laboratory is complex1. Quality control 
is defined as all measures put in place to ensure the 
medical reliability of laboratory data1,2. Quality 
control is now recognized as being a part of a larger 
program referred to as ‘Quality assurance’ (2).        
Quality control activities that take place must be 
recorded to prove their existence1,2. The 
responsibility for QC usually rest with one person, 
but in reality, everybody in the laboratory must 
participate if a program is to be successful1,2. QC 
programs for the medical microbiology laboratory 
should include procedures for control of media, 
temperature, reagents, equipment, susceptibility 




Temperature checks should be done daily on all 
temperature dependent equipments like water bathes, 
incubators, refrigerators, heating blocks and 
freezers17,18 
Thermometers in incubators and refrigerators are 
easier to read when they are permanently immersed 
in glycerol (17,18). Glycerol helps prevent 
temperature fluctuations that occurs when the door is 
opened to read the thermometer17,18. Each 
thermometer must be checked against a reference 
thermometer from the National Institute of Standards 
and Technology (NIST) before each use (17,18).  A 
large batch of thermometers can be checked at the 
same time and at the temperature ranges likely to be 
used (17,18).  Thermometers can also be calibrated by 
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batch on arrival to the laboratory and once the 
thermometer has passed calibration it is placed in 
use17,18. Repeat calibration of in-use thermometers is 
usually not necessary17,18. Certificates of calibration 
of the thermometers are kept for the life of the 
thermometer or until the expiration date on the 
certificate; after that date, the thermometer can be 
recalibrated or discarded17,18. For safety reasons, 
nonmercury thermometers are recommended17,18. 
Mineral spirits with nontoxic, red-dyed alcohol can be 
used in place of the mercury (17,18). 
 
Equipment Quality Control 
 
Equipment used in the clinical microbiology 
laboratory are usually tested for proper performance 
at intervals as appropriate17,18. The frequency of 
testing can vary from daily to yearly depending on 
the equipment in question17,18. A concept termed 
preventive maintenance is put in place to as an 
additional control measure17,18. It involves things 
like replacing filters, oiling and cleaning and 
instrument recalibration (17,18). 
 
Media Quality Control 
 
Media prepared in the medical microbiology 
department must be quality controlled with 
documentation on their performance and 
sterility17,18. Records of these documentation must 
be kept for at least 2 years17,18. Criteria used are 
generated by the Clinical and Laboratory Standards 
Institute (CLSI). Conditions such as moisture; to be 
sure that plates are moisture free before use and also, 
ensure that there are no signs of drying around the 
edges of the media17,18. Culture plates should be free 
of any form of contaminants17,18. Petri dishes should 
not be cracked or broken17,18. The appearance of 
media, blood-based plates for example, should not 
show signs of hemolysis, and also, other plate should 
not deviate from the normal color and should this 
happen, it should not be used (17,18). 
 
Reagent Quality Control 
Reagents like oxidase, kovacs, all stains, catalase, X 
and V strips, Voges-Proskauer and optochin should 
be checked regularly using negative and positive 
controls (17,18). 
Antimicrobial Susceptibility Quality Control 
Guidelines for the control of susceptibility testing is 
provided by CLSI, also provided, is a list of control 
strains from the American Type Culture Collection 
(ATCC) 17,18. The variables that need to be quality 
controlled to ensure release of quality reports include 
instrument failure, antibiotic potency, agar depth, pH, 
evaporation, inoculum concentration, temperature, 
moisture, difficulty in determining endpoints (17,18). 
 
Personnel Competency 
Proficiency testing is usually done to ascertain the 
level of competence of each personnel for each test he 
or she is expected to perform17,18. Review of work 
sheet, written examination and direct observation are 
also ways to determine personnel competence17,18. 
Tests done on patient samples must pass through 
proficiency testing at least twice a year17,18. Another 
form of quality control is the act of reviewing the 
work of a technologist by another, usually a senior 
technologist17,18. Encouraging this practice ensures 
that mistakes are easily caught prior to release of a 
result17,18. Documentation of test of competency for 
each employee must be done on employment and 
yearly from then on and a proof of competency must 
be kept in his or her personnel file( 17,18). 
Stock Cultures 
These can be obtained from various sources including 
commercial sources, patient isolates, ATCC and 
proficiency testing isolates17,18. Stock cultures are 
best grown in large volume and divided into small 
quantities that can be stored for at least a year in 
order to achieve best results (17,18). This reduces the 
risk of organisms mutating during repeated sub-
culturing. Stock cultures can also be stored using 
storage beads. This has the advantage of thawing a 
single bead and the only down side is its higher cost 
margin (17,18).  All organisms stored in a freezer 
should be at -70⁰C17,18. They can also be lyophilized 
or frozen in liquid nitrogen (17,18).   
Quality Control Manual 
This is a document that contains all rules and 
procedures for QC available in written form at the 
work stations for all employees (17,18).  This 
document must be signed after review annually and 
subsequently revised by as supervisor as may be 
needed (17,18).   
CONTROL OF IN-USE ANTISEPTICS  
The importance of laboratory safety in the medical 
microbiology laboratory cannot be 
overemphasized19,20. The attendant risk of an 
individual being exposed to an infectious agent while 
working in the medical microbiology laboratory 
increases with the type of the organism, frequency of 
working on it and level of contact with the infectious 
agent19,20. This is why there must be appropriate 
systems in place to ensure antisepsis in th laboratory 
and also ensure the continuous control of these in-use 




An antiseptics’ effectiveness against the expected 
spectrum of pathogens is a prerequisite for an 
antiseptic agent (19-21).. Antiseptics used in the 
medical microbiology laboratory includes alcohols 
and iodine (19,20). 
Ethyl alcohol and isopropyl alcohol are the two most 
effective alcohols used19-21.  A solution of an alcohol 
that is to be used for antiseptic purposes is usually 
filtered through a 0.22-µm filter to remove any spores 
that may be present (19-21).  Alcohols are not 
sporicidal, so, a sterile cotton ball should be used 
when they are used to saturate cotton balls to be used 
to prepare the skin for blood collection or inoculation 
(19-21).  Alcohols should only be used in 
concentrations between 60% and 90% and, they must 
be allowed to evaporate from the surface to which 
they were applied for them to be effective19-21. The 
presence of organic materials easily inactivates 
alcohols (19-21). 
Iodine 
Iodine tinctures are alcohol and iodine solutions, used 
mainly as antiseptics and povidone-iodine is the best 
known iodophor used in the medical microbiology 
laboratory19,20. Povidone-iodine provides a slow and 
continuous release of free iodine19,20.  They are 
commonly used as skin preparations from sites where 
blood is to be drawn19,20.  It is important that there is 
proper amount of contact time when using it as it 
usually requires more than 30 seconds 19,20.. Iodine 
tinctures and iodophors must be completely removed 
from the skin to avoid irritation of the skin (19-21). 
 
Quality Control Programs in the Medical Mycology 
Laboratory 
The field of medical mycology has rapidly advanced 
over the last few decades, with tentacles twinning on 
many specialities of clinical medicine. The spectrum 
of diseases caused by fungi range from 
asymptomatic/mild mucocutaneous diseases e.g. 
dermatophytoses and vulvo-vaginal candidiasis, to 
chronic debilitating e.g. mycetoma and chronic 
pulmonary aspergillosis (CPA), to severe life-
threatening invasive fungal disease (IFD) e.g. 
cryptococcal meningitis. In total, more than 1.5 
million people die annually of fungal diseases 
worldwide22. Aspergillus spp., Cryptococcus spp., 
Candida spp., and Pneumocystis jirovecii are the main 
etiologic pathogens of IFD worldwide. Other 
clinically significant pathogens include the agents of 
mucormycosis, endemic mycoses, the dermatophytes, 
and other yeasts and moulds (23). 
Timely and accurate diagnosis of IFD is essential but 
challenging because of the nonspecific clinical and 
radiographic findings, underlying co-morbid 
conditions that impedes potentially definitive 
diagnostic procedures24. Culture and culture-based 
methods of diagnosis allow species level 
identification and antifungal susceptibility testing, 
however, conventional cultures have low yield (24). 
Culture-independent serum antigen detection tests, 
such as the β-1,3-D-glucan (BDG) assay- a 
“panfungal” biomarker, Aspergillus-specific IgG – a 
key assay for the serological diagnosis of CPA, 
cryptococcal antigen (CrAg) tests – a lateral flow 
assay that has revolutionised the screening and 
diagnosis of cryptococcal disease, and galactomannan 
(GM) index-for the diagnosis of invasive pulmonary 
aspergillosis, may allow earlier diagnosis of IFD than 
is otherwise feasible with traditional methods (25-27). 
Early initiation of antifungals is key to survival and 
recovery. Therapeutic drug monitoring (TDM) allows 
treatment optimisation by ensuring therapeutic 
antifungal serum levels. Available methods for 
antifungal TDM includes the bioassay, high 
performance liquid chromatography, liquid 
chromatography-mass spectrometry and tandem 
mass spectrometry, each with its own advantages and 
disadvantages28. Bioassay is the preferred method to 
measure flucytosine and itraconazole levels. Quality 
control assessment is a key requirement for triazole 
TDM (29). 
The Global action Fund for Fungal Infections in its 
action plan aims at developing a more regional or 
continental EQA schemes for medical mycology, with 
a focus on assessing immunoassays (antibody and 
antigen tests), and molecular assays (30), these 
schemes should also include antifungal drug 
monitoring. Thus, the aim of an external assurance 
scheme in medical mycology would be focused at 
assessing (31,32);  
1) Processing of clinical specimens for the 
diagnosis of fungal diseases 
2) The actual identification of the pathogenic 
fungi (yeast or mould) isolated 
3) Interpretation of results of identification 
(colonisation?, contaminant? or true 
infection?) 
4) Serological and biomarker tests for invasive 
fungal diseases 
5) Antifungal susceptibility testing of 
pathogenic fungi 
6) Methodologies and techniques of therapeutic 
drug monitoring, and 
7) Molecular and proteomic methods of 
identification of pathogenic fungi. 
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The ultimate goal of the exercise is to ensure that the 
laboratory results that are being reported are 
accurate, reliable and reproducible33. The internal 
control programme consists of various tests to check 
the reagents including the culture media and other 
consumable materials34. In the laboratory, reference 
strains have to be provided and, preparation of 
reagents are needed (34).  
Competence of the technical staff in the laboratory 
can also be maintained through the identification 
process of unknown fungal strains34. The use of the 
international standards to identify competence in the 
laboratory results has improved the confidence and 
acceptance of laboratory results worldwide32. This 
can also be used in identifying the training needs of 
members of technical staff as well as evaluating and 
improving the performance of the laboratory31. 
However, issues have been raised considering the 
reliability of these testing procedures which only 
measure the overt proficiency testing (OPT) targeted 
at the optimal performance of the laboratory rather 
than being directed at the routine processes of the 
patients’ samples (35). Another way of improving 
external quality assurance is to encourage the global 
registry which usually gives up to date information 
on rare and emerging fungal diseases (36). 
Instructions on every routine procedure being 
performed must be readily available and it must have 
been those that have been properly evaluated in a 
competent manner33. A record of the dates when all 
media, reagents and stains to be used in medical 
mycology laboratory was first received, first opened 
and when to be discarded must be properly recorded 
(33). Supplies, equipment and the work area in the 
mycology laboratory must be maintained in an 
orderly manner to be able to maintain an efficient 
work flow (33). The equipment used must meet 
manufactures specifications. In the diagnostic medical 
mycology laboratory, preservation of the strains of 
fungi isolated should be kept alive for further 
evaluation for molecular identification, antifungal 
susceptibility testing and, epidemiological 
purposes34. The techniques for this, usually require 
serial sub-culturing as well as storage in liquid 
nitrogen, glycerol (10%) (at -20oC and -80oC) and 
lyophilisation. This also serves as the stock culture for 
the quality control organisms (31).  
A new strain of fungus isolated in the diagnostic 
medical laboratory should be sent to the reference 
medical laboratory for further identification and final 
confirmation. A properly-labelled screw cap tubes 
with masking tape should be used35. There are 
different types of fungal culture media that are used 
for the isolation, identification and maintenance of the 
fungal strains. The performance of both laboratory 
and commercially prepared media must be 
monitored. A record containing the identification of 
the media, preparation, packaging evaluation as well 
as sterility check. The medium should be inoculated 
with the appropriate test organisms that produce 
negative and positive reactions (33).  
On the African continent, a typical example of an 
EQA scheme is that of the National Health Laboratory 
Service (NHLS) Proficiency Testing Scheme (PTS) for 
Mycology, which operates across all NHLS 
laboratories in South Africa and laboratories in over 
20 countries across Africa. NHLSPTS conducts three 
surveys per year, with each survey including, 4 
mould and 1 yeast isolates for identification, slide 
preparation for microscopy, a simulated blood or 
cerebrospinal fluid samples for cryptococcal antigen 
testing, and 1 yeast isolate for identification and 
antifungal susceptibility testing (37).  However, a real 
world experience on EQAS from seven countries on 
laboratory practices for diagnosis of fungal infection 
reported by the Asia Fungal Working Group initiative 
showed that only 56% of the labs participated in an 
EQAS, and only 43% conducted regular formal staff 
training (38). There is clearly a need to facilitate 
improved participation, as this will lead to improved 
laboratory performance in the mid-term. 
Fungal diseases are an emerging threat to the public 
health worldwide, they are difficult to diagnose and 
treat. The true burden of fungal diseases in many 
countries across the world remains unknown; due 
both non-existence of mycologists and very limited 
availability of good, dedicated diagnostic mycology 
laboratories. EQA schemes allow specialist tests to be 
done outside of the reference laboratory in general 
laboratories reliably. Furthermore, EQA schemes 
enhances patient care and safety through improved 
laboratory practice.  
There is need for programs to ensure the 
comparability of data among testing laboratories 
across different continents. In the past the differences 
in quality programmes operated in laboratories made 
this difficult however Laboratory accreditation 
programs on quality standards such as EN 45000 
series and ISO Guide 25 has facilitated reproducibility 
in the data produced by different laboratories across 
the world thus ensuring wider acceptability and 
reproducibility of the data.  The ISO 15189 for 
Medical Laboratories states that the laboratory shall 
participate in organised inter-laboratory comparisons, 
such as external quality assessment schemes, that 
encompass the extent and complexity of examination 
procedures used by the laboratory and the laboratory 
management shall monitor the results of external 
quality assessment and participate in the 
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implementation of corrective actions when control 
criteria are not fulfilled.  
The objectives of an EQA are; to provide a measure 
for individual laboratory quality, to supplement 
internal quality control procedures, to provide a 
measure of the “state of the art” for a test, to obtain 
consensus values when true values are unknown, to 
investigate factors in performance (methods, staff etc) 
and to act as an educational stimulus to improvement 
in performance. In the case of microbiology EQA, the 
responses are evaluated against a predetermined 
intended response (e.g. the identity of the organism 
and its antimicrobial susceptibility pattern). The key 
steps towards a successful EQA as outlined by the 
Centre for Disease control involves the following 
steps occurring in a continuous cycle; defining the 
problems, planning for an EQA, implementing the 
EQA, follow up the EQA and finally to review and 
strategically plan the EQA. 
EXTERNAL QUALITY CONTROL 
With less restriction on trade throughout the world 
the comparability of data among testing laboratories 
becomes all the more important. In the past the 
differences in quality programmes operated in 
laboratories made this difficult. Laboratory 
accreditation to quality standards such as EN 45000 
series and ISO Guide 25 [4] has given creditability to 
data produced by laboratories and has ensured wider 
acceptability of the data. Many European countries 
with national accreditation bodies now have 
multilateral recognition agreements 
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